ODI Pharma AB
ODI | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0013409760 (+2 more)
- LEI:
- 8945001MNHCQFIP27M14
- Country:
- Sweden
- Address:
- Östermalmstorg 1, 114 42 Stockholm
- Website:
- https://www.odipharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales go through wholesale distributors and pharmacies. The products are used for the treatment of multiple sclerosis, chronic pain, and chemotherapy. ODI Pharma operates in the European market and is headquartered in Stockholm.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
D.Western Therapeutics Institute, Inc. | Japan | 4576 | |
|
EARNZ PLC | United Kingdom | EARN | |
|
Eevia Health Plc | Finland | EEVIA | |
|
Egetis Therapeutics | Sweden | EGTX | |
|
EIKEN CHEMICAL CO.,LTD. | Japan | 4549 | |
|
Eisai Co., Ltd. | Japan | 4523 | |
|
ELARIS AG | Germany | ELS | |
|
Enervit | Italy | ENV | |
|
Enorama Pharma AB | Sweden | ERMA | |
|
Enzymatica AB | Sweden | ENZY |